Literature DB >> 7862144

A novel enhancer, the pro-B enhancer, regulates Id1 gene expression in progenitor B cells.

S Saisanit1, X H Sun.   

Abstract

The helix-loop-helix (HLH) Id proteins have been reported to function as inhibitors of various differentiation programs. The HLH motif mediates dimer formation between Id and the basic HLH transcription factors. Since Id proteins lack the basic region responsible for DNA binding, the heterodimers cannot bind to DNA. Id proteins have also been found to be involved in early B-cell differentiation. They are expressed at high levels in progenitor B cells (pro-B cells), and the expression is diminished in pre-B cells and mature B cells. This expression pattern correlates inversely with basic HLH protein activity and immunoglobulin enhancer function in B-cell development. Regulation of Id expression may play an important role in transcriptional control of immunoglobulin genes and therefore in B-cell differentiation. We have characterized the regulatory elements of the Id1 gene. Using stable transfectants, transient transfection, and mobility shift assays, we have identified an 8-bp element designated PBE (pro-B enhancer) downstream of the Id1 gene that is responsible for a pro-B-cell-specific enhancer activity. A pro-B-cell-specific protein complex was found to bind to the 8-bp PBE element. Substitution mutagenesis at this binding site showed that it is indeed of functional importance in regulating the pro-B-cell-specific expression of the Id1 gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862144      PMCID: PMC230375          DOI: 10.1128/MCB.15.3.1513

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene.

Authors:  B A Christy; L K Sanders; L F Lau; N G Copeland; N A Jenkins; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

2.  Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif.

Authors:  P Henthorn; M Kiledjian; T Kadesch
Journal:  Science       Date:  1990-01-26       Impact factor: 47.728

3.  Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line.

Authors:  M Schlissel; A Voronova; D Baltimore
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

Review 4.  Molecular and cellular origins of B lymphocyte diversity.

Authors:  A Rolink; F Melchers
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

5.  Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.

Authors:  J M Pongubala; M L Atchison
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

6.  B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits.

Authors:  C Murre; A Voronova; D Baltimore
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

8.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

9.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

Review 10.  The myoD gene family: nodal point during specification of the muscle cell lineage.

Authors:  H Weintraub; R Davis; S Tapscott; M Thayer; M Krause; R Benezra; T K Blackwell; D Turner; R Rupp; S Hollenberg
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

View more
  7 in total

1.  Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1.

Authors:  O Tournay; R Benezra
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

2.  Id3 prevents differentiation of preadipose cells.

Authors:  M Moldes; F Lasnier; B Fève; J Pairault; P Djian
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

3.  Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.

Authors:  Katharina Wagner; Pu Zhang; Frank Rosenbauer; Bettina Drescher; Susumu Kobayashi; Hanna S Radomska; Jeffery L Kutok; D Gary Gilliland; Jürgen Krauter; Daniel G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

4.  Regulation of the pro-B-cell-specific enhancer of the Id1 gene involves the C/EBP family of proteins.

Authors:  S Saisanit; X H Sun
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

5.  STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta.

Authors:  Min Xu; Lei Nie; Seung-Hwan Kim; Xiao-Hong Sun
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

Review 6.  The Id-protein family in developmental and cancer-associated pathways.

Authors:  Cornelia Roschger; Chiara Cabrele
Journal:  Cell Commun Signal       Date:  2017-01-25       Impact factor: 5.712

7.  CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers.

Authors:  Seung-Kyoon Kim; Hay-Ran Jang; Jeong-Hwan Kim; Mirang Kim; Seung-Moo Noh; Kyu-Sang Song; Gyeong Hoon Kang; Hee Jin Kim; Seon-Young Kim; Hyang-Sook Yoo; Yong Sung Kim
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.